Keyword: ImmunoCellular Therapeutics

SEC hits out at paid-for bioanalysts, CEOs and firms, charges 27

The Securities and Exchange Commission (SEC) has charged 27 companies and individuals over allegations of fraudulent promotion of stocks, as it says it has uncovered a number of writers, sometimes paid by biotech CEOs and comms firms, dressing up unbiased reporting while secretly being paid to tout a company stock.